The content on this page was provided by an independent third party and syndicated by XPR Media. Members of the editorial and news staff of the USA TODAY Network were not involved in the creation of this content.
TRUMBULL, CONNECTICUT / ACCESS Newswire / June 24, 2025 / The sam®2.0 wearable ultrasound unit from ZetrOZ Systems has been documented in multiple clinical studies as an effective treatment for knee osteoarthritis, as well as a spectrum of soft-tissue injuries. The sam® 2.0 has received the Arthritis Foundation’s Ease of Use® Certification signifying this is easier to use for people living with arthritis and chronic pain.
Connecticut-based ZetrOZ Systems is the inventor of sustained acoustic medicine, a long-duration, continuous, multi-hour, high frequency ultrasound treatment cleared by the U.S. Food and Drug Administration for treating soft-tissue injuries.
The Arthritis Foundation’s Ease of Use® seal certifies products and packaging that have been tested and proven to make life easier for people with arthritis. Nearly 60 million U.S. adults – about 1 in 4 – and hundreds of children have been diagnosed with arthritis and live with pain that limits their daily activities.
“We’re extremely pleased that the sam® 2.0 device has received the Arthritis Foundation’s Ease of Use® certification.” said George K. Lewis, founder and CEO of ZetrOZ Systems. ” We are proud to support the Foundation’s mission to improve the quality of life for people living with arthritis.
ZetrOZ Systems’ sam® X1 and sam® 2.0 wearable ultrasound devices treat osteoarthritis and other soft-tissue injuries with mechanobiological technology that provides deep warming, expanding blood vessel diameters and improving blood flow. That increases oxygenated hemoglobin and removes cytokine enzymes and cellular waste, accelerating the healing process.
The sam® device’s effectiveness is validated by over 30 clinical studies and more than 3.7 million treatments of patients nationwide. For more information, please visit https://zetroz.com/ or samrecover.com. To learn more about the Ease of Use program, please visit arthritis.org/easeofuse.
About ZetrOZ Systems ZetrOZ Systems is leading healing innovations in sports medicine, developing wearable bioelectronic devices to deliver sustained acoustic medicine (sam®). Researched and funded by the federal government, ZetrOZ is built on the proprietary medical technology of 48 patents and is the exclusive manufacturer and developer of the sam® product line, designed to treat acute and chronic musculoskeletal conditions.
About the Arthritis Foundation The Arthritis Foundation’s mission is to turn the obstacles arthritis causes into opportunities. The Arthritis Foundation champions life-changing solutions and medical advancements, and it also provides ways for people to connect, break down barriers in health care and join the fight for a cure – uniting hearts, minds and resources to change the future of arthritis. To join the fight to conquer arthritis, visit arthritis.org.
Information contained on this page is provided by an independent third-party content provider. XPRMedia and this Site make no warranties or representations in connection therewith. If you are affiliated with this page and would like it removed please contact pressreleases@xpr.media
All matters presented for shareholder approval were overwhelmingly approved TORONTO, ON / ACCESS Newswire / June 25, 2025 / Cerrado Gold Inc. (TSXV:CERT)(OTCQX:CRDOF) (“Cerrado” or…
VANCOUVER, BC AND BREDA, THE NETHERLANDS / ACCESS Newswire / June 25, 2025 / Organto Foods Inc. (TSX-V:OGO)(OTC PINK:OGOFF)(FSE:OGF) (“Organto” or “the Company”) today announced…
Client-Focused Strategist Elevated to Lead Key Dealership Partnerships SCOTTSDALE, AZ / ACCESS Newswire / June 25, 2025 / Phone Ninjas, the automotive industry’s leader in…
KITON Segment Surpasses 1 Million Views as New to The Street Continues to Dominate Financial Media Across Broadcast, Digital, and Outdoor Platforms NEW YORK CITY,…
June 28 is dedicated to reviewing insurance policies, understanding and learning about coverage options, and ensuring comprehensive protection for individuals and businesses OVERLAND PARK, KS…
MIAMI, FL / ACCESS Newswire / June 25, 2025 / iTolerance, Inc. (“iTolerance” or the “Company”), an early-stage privately-held biotechnology company focused on the development…
Medical equipment provider delivers on-demand solutions for patients with high BMIs HOUSTON, TX / ACCESS Newswire / June 25, 2025 / As the nation confronts…
Rhode Island manufacturer’s latest environment monitoring solution recognized for exceptional simplicity, ease of use, and seamless integration capabilities WARREN, RI / ACCESS Newswire / June…
Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public…
Global Market Leader in Payment Fraud Prevention Joins Forces With France-Based Sis ID, Where the Combined Entity Will Now Provide Payment Protection in More Markets…
Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs Jaguar is exploring the…
The capital will drive market expansion, fuel product innovation, and enable acquisitions to help energy producers power the AI-driven future. AUSTIN, TX / ACCESS Newswire…
MIAMI, FL / ACCESS Newswire / June 25, 2025 / MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) (“MIRA” or the “Company”), a clinical-stage pharmaceutical company focused on developing…
Recognized for revolutionizing large file transfer and management workflows in sports, news, and high-volume media production OTTAWA, ON / ACCESS Newswire / June 25, 2025…
New Central Virginia campus expands EdgeCore’s Virginia data center portfolio to over 1.6GW DENVER, CO / ACCESS Newswire / June 25, 2025 / EdgeCore Digital…
Reverse Split Becomes Effective Friday, June 27, 2025 Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued…
TAMPA, FL / ACCESS Newswire / June 25, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX), a healthcare technology company focused on building the future of prescription…
TORONTO, ON / ACCESS Newswire / June 25, 2025 / Electrovaya Inc. (“Electrovaya” or the “Company”) (NASDAQ:ELVA)(TSX:ELVA), a leading lithium-ion battery technology and manufacturing company,…
Advancement of long lead work programs to support ML Application HIGHLIGHTS Recent Tunkillia OSS confirms large-scale gold project yielding $2.7bn operating cash[1] Barton accelerating key…
BOCA RATON, FL / ACCESS Newswire / June 24, 2025 / Greenlane Holdings, Inc. (NASDAQ:GNLN) (“Greenlane”), a global seller of premium cannabis accessories, child-resistant packaging,…
Company’s CEO, board members, other C-suite members, and institutional and accredited investors are participants in the extension of the bridge financing SAN FRANCISCO, CA /…
SAN DIEGO, CALIFORNIA / ACCESS Newswire / June 24, 2025 / General Atomics Electromagnetic Systems (GA-EMS) announced today that it has reached another significant milestone…
SAN BERNARDINO, CA / ACCESS Newswire / June 24, 2025 / Dateline Resources Limited (ASX:DTR)(OTCQB:DTREF), a leading Australian mining and exploration company, today announced that…
AstroNova breached confidentiality, misrepresented private negotiations Company demanded silence in exchange for no Board seats, no leadership change, and no path to value creation Board…
Upstate Makes champions glass packaging as part of NSF Regional Innovation Engines proposal, spearheads development of a glass innovation and training hub June 25 event…
NORTHWOOD, OH / ACCESS Newswire / June 24, 2025 / Telesystem, a leading provider of nationwide managed technology solutions, is excited to announce the return…
With over 150 serviced sites and 100 industry customers and partners, the industrial battery services leader reaches a major milestone-demonstrating the value of full-lifecycle battery…
